Ovid Therapeutics to Discuss Positive Initial Data from Ongoing ENDYMION Trial Call Transcript - Thomson StreetEvents

Ovid Therapeutics to Discuss Positive Initial Data from Ongoing ENDYMION Trial Call Transcript

Ovid Therapeutics to Discuss Positive Initial Data from Ongoing ENDYMION Trial Call Transcript - Thomson StreetEvents
Ovid Therapeutics to Discuss Positive Initial Data from Ongoing ENDYMION Trial Call Transcript
Published Sep 23, 2019
Published Sep 23, 2019
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of OVID.OQ conference call or presentation 23-Sep-19 12:00pm GMT

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Ovid Therapeutics Inc
Ticker
OVID.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Ovid Therapeutics Inc. - Special Call Transcript – 2020-10-22 – US$ 54.00 – Edited Transcript of OVID.OQ conference call or presentation 22-Oct-20 5:00pm GMT

Ovid Therapeutics Inc. - Special Call Transcript – 2020-08-25 – US$ 54.00 – Edited Transcript of OVID.OQ conference call or presentation 25-Aug-20 12:00pm GMT

Ovid Therapeutics Inc. - Special Call Transcript – 2020-07-13 – US$ 54.00 – Edited Transcript of OVID.OQ conference call or presentation 13-Jul-20 12:15pm GMT

Ovid Therapeutics Inc. - Special Call Transcript – 2020-06-17 – US$ 54.00 – Edited Transcript of OVID.OQ conference call or presentation 17-Jun-20 5:00pm GMT

Ovid Therapeutics Inc Annual Shareholders Meeting Transcript – 2020-06-04 – US$ 54.00 – Edited Transcript of OVID.OQ shareholder or annual meeting 4-Jun-20 3:00pm GMT

Ovid Therapeutics Inc. - Special Call Transcript – 2019-06-27 – US$ 54.00 – Edited Transcript of OVID.OQ conference call or presentation 27-Jun-19 4:00pm GMT

Ovid Therapeutics Inc. - Special Call Transcript – 2018-12-17 – US$ 54.00 – Edited Transcript of OVID.OQ conference call or presentation 17-Dec-18 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Ovid Therapeutics to Discuss Positive Initial Data from Ongoing ENDYMION Trial Call Transcript" Sep 23, 2019. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Ovid-Therapeutics-to-Discuss-Positive-Initial-Data-from-Ongoing-ENDYMION-Trial-Call-T12746959>
  
APA:
Thomson StreetEvents. (2019). Ovid Therapeutics to Discuss Positive Initial Data from Ongoing ENDYMION Trial Call Transcript Sep 23, 2019. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Ovid-Therapeutics-to-Discuss-Positive-Initial-Data-from-Ongoing-ENDYMION-Trial-Call-T12746959>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.